Anteris Technologies Global (AVR) Competitors $4.74 +0.17 (+3.72%) As of 10/15/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVR vs. SIBN, BFLY, BVS, ZIMV, AVNS, CBLL, KIDS, SMLR, TMCI, and DCTHShould you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include SiBone (SIBN), Butterfly Network (BFLY), Bioventus (BVS), ZimVie (ZIMV), Avanos Medical (AVNS), CeriBell (CBLL), OrthoPediatrics (KIDS), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Anteris Technologies Global vs. Its Competitors SiBone Butterfly Network Bioventus ZimVie Avanos Medical CeriBell OrthoPediatrics Semler Scientific Treace Medical Concepts Delcath Systems SiBone (NASDAQ:SIBN) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends. Does the media prefer SIBN or AVR? In the previous week, SiBone and SiBone both had 4 articles in the media. Anteris Technologies Global's average media sentiment score of 0.94 beat SiBone's score of 0.62 indicating that Anteris Technologies Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SiBone 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Anteris Technologies Global 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings and valuation, SIBN or AVR? SiBone has higher revenue and earnings than Anteris Technologies Global. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiBone$167.18M3.93-$30.91M-$0.56-27.18Anteris Technologies Global$2.70M63.31-$76.29MN/AN/A Is SIBN or AVR more profitable? Anteris Technologies Global has a net margin of 0.00% compared to SiBone's net margin of -12.83%. Anteris Technologies Global's return on equity of 0.00% beat SiBone's return on equity.Company Net Margins Return on Equity Return on Assets SiBone-12.83% -14.20% -10.38% Anteris Technologies Global N/A N/A N/A Do analysts recommend SIBN or AVR? SiBone presently has a consensus price target of $23.00, indicating a potential upside of 51.12%. Anteris Technologies Global has a consensus price target of $16.50, indicating a potential upside of 248.10%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than SiBone.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SiBone 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Anteris Technologies Global 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Do insiders & institutionals believe in SIBN or AVR? 98.1% of SiBone shares are owned by institutional investors. 4.0% of SiBone shares are owned by insiders. Comparatively, 4.0% of Anteris Technologies Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryAnteris Technologies Global beats SiBone on 8 of the 11 factors compared between the two stocks. Get Anteris Technologies Global News Delivered to You Automatically Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVR vs. The Competition Export to ExcelMetricAnteris Technologies GlobalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$164.80M$7.05B$6.11B$10.46BDividend YieldN/A1.18%5.73%4.77%P/E RatioN/A26.2685.3627.36Price / Sales63.3127.41601.96132.92Price / CashN/A21.7037.4661.86Price / Book2.725.2112.426.81Net Income-$76.29M$178.09M$3.32B$276.80M7 Day Performance-3.07%-1.83%0.57%0.42%1 Month Performance-16.99%6.30%10.52%7.86%1 Year PerformanceN/A4.63%72.99%41.24% Anteris Technologies Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVRAnteris Technologies Global1.9567 of 5 stars$4.74+3.7%$16.50+248.1%N/A$164.80M$2.70M0.00138News CoverageGap DownSIBNSiBone3.9472 of 5 stars$14.78-6.0%$23.67+60.1%+15.8%$637.62M$185.26M-26.39350Analyst ForecastBFLYButterfly Network3.0041 of 5 stars$2.28-11.5%$3.00+31.9%+40.6%$572.71M$82.06M-8.13460High Trading VolumeBVSBioventus1.3539 of 5 stars$6.51-1.2%N/AN/A$538.25M$573.28M13.521,200News CoverageZIMVZimVie1.1701 of 5 stars$18.96+0.2%$17.75-6.4%+27.0%$534.86M$449.75M-27.091,770AVNSAvanos Medical1.5065 of 5 stars$10.73-4.6%N/A-50.2%$497.89M$692.50M-1.072,227Positive NewsAnalyst ForecastCBLLCeriBell2.2791 of 5 stars$11.95-6.8%$32.14+169.0%N/A$438.09M$65.44M-4.00N/AKIDSOrthoPediatrics4.6207 of 5 stars$16.30-9.2%$26.29+61.3%-34.0%$408.71M$220.73M-9.11200High Trading VolumeSMLRSemler Scientific3.2006 of 5 stars$26.80-5.4%$74.25+177.1%-6.8%$405.81M$42.98M11.03120TMCITreace Medical Concepts2.3248 of 5 stars$5.88-2.5%$9.83+67.2%+15.0%$371.44M$209.36M-7.44250Analyst ForecastDCTHDelcath Systems2.438 of 5 stars$10.46-3.9%$24.50+134.2%+26.8%$365.90M$70.24M209.2060 Related Companies and Tools Related Companies SIBN Alternatives BFLY Alternatives BVS Alternatives ZIMV Alternatives AVNS Alternatives CBLL Alternatives KIDS Alternatives SMLR Alternatives TMCI Alternatives DCTH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVR) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anteris Technologies Global Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anteris Technologies Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
